The Lancet Oncology Commission on Medical Imaging and Nuclear Medicine was established in 2018, with the charge of examining global access to imaging and nuclear medicine for cancer care. The Commission brings together 17 leading global experts and the final report is peer reviewed and published in The Lancet Oncology. The report follows two previous Lancet Oncology Commissions in 2015 that assessed the gaps in access to cancer surgery and radiotherapy, and proposed actions to address the growing burden of cancer in LMICs.

The Lancet Oncology Commission on Medical Imaging and Nuclear Medicine is supported by the following 27 organizations: the African Association of Nuclear Medicine, the American College of Radiology, the Association of Latin American Societies of Biology and Nuclear Medicine, the Australian and New Zealand Society of Nuclear Medicine, the Asia Oceania Federation of Nuclear Medicine and Biology, the African Organisation for Research & Training in Cancer, the American Society of Clinical Oncology, the Arab Society of Nuclear Medicine, the African Society of Radiology, the American Society for Radiation Oncology, the Breast Cancer Research Foundation, the European Association of Nuclear Medicine, the European Society for Medical Oncology, the European Society of Radiology, the European Society for Radiotherapy and Oncology, the Hong Kong College of Radiologists, the International Atomic Energy Agency, the International Society for Strategic Studies in Radiology, the International Society of Radiology, the National Cancer Institute, the Pan-Arab Association of Radiological Societies, the Radiological Society of North America, the South African Society of Nuclear Medicine, the Society of Nuclear Medicine & Molecular Imaging, the Union for International Cancer Control, the World Federation of Nuclear Medicine and Biology, and the World Molecular Imaging Society.

SOURCE European Congress of Radiology

Back to HCB News

Molecular Imaging Homepage